Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Hidden fungal infections might cause heart disease and clogged arteries.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

Higher apelin-12 levels may indicate more severe acne.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

People with alopecia areata have higher insulin resistance.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Hair loss may be linked to cardiovascular health problems.

Alopecia areata may be linked to heart issues.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Men with early-onset hair loss have more heart disease risk factors.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Anabolic-androgenic steroids increase the risk of heart problems.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

DHT causes thicker and less elastic skin, linked to hair loss.